Autofluorescence endoscopy (AFE) has a higher sensitivity for the detection of colorectal adenomas in comparison with white light video endoscopy (WLE).
ID
Bron
Verkorte titel
Aandoening
Lynch syndrome, familial colorectal cancer
colonoscopic surveillance
Dutch:
Lynch syndroom
familiaire colorectaal carcinoom
colonoscopische surveillance
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The difference between WLE and AFE for detection of adenomatous lesion or CRC during colonoscopy in patient with HNPCC or familial CRC.
Achtergrond van het onderzoek
Objective:
To compare the sensitivity of autofluorescence endoscopy (AFE) and white light video endoscopy (WLE) for the detection of colorectal adenomas in high-risk patients belonging to Lynch syndrome (LS) or familial colorectal cancer (CRC) families.
Design:
Prospective single centre study.
Setting:
Tertiary referral centre.
Population:
Asymptomatic patients originating from Lynch syndrome or familial colorectal cancer families.
Intervention:
Patients were examined with either WLE followed by AFE or AFE followed by WLE. Back-to-back colonoscopy was performed by two blinded endoscopists. All lesions were removed during the second endoscopic procedure. Lesions missed during the second procedure were identified and removed on 3rd pass. The sensitivity calculations for colorectal adenomas were based on histology results.
Outcome measure:
The difference in sensitivity between WLE and AFE for the detection of adenomas in patients with LS or familial CRC.
Analysis:
McNemar’s test, the Mann-Whitney U test, the Fisher exact test, the t-test and multivariable proportional odds logistic regression analysis.
Doel van het onderzoek
Autofluorescence endoscopy (AFE) has a higher sensitivity for the detection of colorectal adenomas in comparison with white light video endoscopy (WLE).
Onderzoeksopzet
Interim analysis after inclusion of fifty participants.
Onderzoeksproduct en/of interventie
Colonoscopic surveillance with both WLE and AFE in high risk patients (Lynch syndrome or familial colorectal cancer). In case of the detection of colorectal lesions (adenoma, colorectal cancer or hyperplasia) these lesions were removed by polypectomy. AFE was compared to WLE (active control) with respect to the diagnostic yield (detection of colorectal lesions).
Publiek
Erasmus MC University Medical Center
's 's Gravendijkwal 230
D. Ramsoekh
Dept. of Gastroenterology and Hepatology
Erasmus MC University Medical Center
's 's Gravendijkwal 230
Rotterdam 3015 CE
The Netherlands
+31 10 70 34681
d.ramsoekh@erasmsumc.nl
Wetenschappelijk
Erasmus MC University Medical Center
's 's Gravendijkwal 230
D. Ramsoekh
Dept. of Gastroenterology and Hepatology
Erasmus MC University Medical Center
's 's Gravendijkwal 230
Rotterdam 3015 CE
The Netherlands
+31 10 70 34681
d.ramsoekh@erasmsumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Age 18 years or older;
2. Patients with Lynch syndrome, defined
according to the Amsterdam 2 criteria;
3. Patients with familial colorectal cancer
(IKR Guidelines; www.oncoline.nl):
A. One first degree family member with
colorectal carcinoma diagnosed at a
relative young age or in two second
degree family members and;
B. Lynch syndrome or Familial
adenomatous polyposis is excluded.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Under 18 years of age;
2. Patients with (attenuated) FAP;
3. Coagulopathy (prothrombin time < 50%
of control; partial thromboplastin time >
50 seconds) or anticoagulantia that can
not be discontinued;
4. Patients with inflammatory bowel disease;
5. Patients with Peutz-Jeghers syndrome or
juvenile polyposis;
6. Patients unable or not willing to give
informed consent.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL1756 |
NTR-old | NTR1865 |
Ander register | Medical ethical committee Erasmus MC University Medical Center : MEC-2005-199 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |